Patents by Inventor Birgit Kjaeldgaard Giwercman

Birgit Kjaeldgaard Giwercman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THIOXANTHENE DERIVATIVES FOR THE TREATMENT OF INFECTIOUS DISEASES
    Publication number: 20140066451
    Abstract: The claimed subject matter is directed to certain thioxanthene derivatives and phenothiazine derivatives suitable for use as anti-infective agents, in particular, for the treatment of infectious diseases. The claimed subject matter furthermore relates to compositions including said anti-infective agents.
    Type: Application
    Filed: November 4, 2013
    Publication date: March 6, 2014
    Applicant: BKG PHARMA APS
    Inventor: Birgit Kjaeldgaard GIWERCMAN
  • Thioxanthene derivatives for the treatment of infectious diseases
    Patent number: 8604059
    Abstract: The claimed subject matter is directed to certain thioxanthene derivatives and phenothiazine derivatives suitable for use as anti-infective agents, in particular, for the treatment of infectious diseases. The claimed subject matter furthermore relates to compositions including said anti-infective agents.
    Type: Grant
    Filed: April 20, 2010
    Date of Patent: December 10, 2013
    Assignee: BKG Pharma APS
    Inventor: Birgit Kjældgaard Giwercman
  • THIOXANTHENE DERIVATIVES FOR THE TREATMENT OF INFECTIOUS DISEASES
    Publication number: 20120122880
    Abstract: The claimed subject matter is directed to certain thioxanthene derivatives and phenothiazine derivatives suitable for use as anti-infective agents, in particular, for the treatment of infectious diseases. The claimed subject matter furthermore relates to compositions including said anti-infective agents.
    Type: Application
    Filed: April 20, 2010
    Publication date: May 17, 2012
    Applicant: BKG PHARMA APS
    Inventor: Birgit Kjaeldgaard Giwercman
  • THIOXANTHENE DERIVATES USEFUL TO TREAT INFECTIOUS DISEASES
    Publication number: 20100113430
    Abstract: The present invention is directed to certain thioxanthene derivatives and phenothiazine derivatives suitable for use as anti-infective agents, in particular, for treatment of infectious diseases. The invention furthermore relates to compositions comprising said anti-infective agents.
    Type: Application
    Filed: January 7, 2008
    Publication date: May 6, 2010
    Applicant: BKG PHARMA APS
    Inventor: Birgit Kjældgaard Giwercman
  • Treatment of Infectious Diseases
    Publication number: 20080318970
    Abstract: The present invention is directed to the use of chemosensitising compounds, in particular thioxanthene derivatives and phenothiazine derivatives, for treatment of infectious diseases in combination with an anti-infective agent. The invention furthermore relates to compositions comprising said chemosensitising compounds and anti-infective agents.
    Type: Application
    Filed: April 29, 2005
    Publication date: December 25, 2008
    Inventor: Birgit Kjaeldgaard Giwercman
  • Modified peptide nucleic acid (PNA) molecules
    Publication number: 20030199431
    Abstract: The present invention relates to novel drugs which may be used in combating infectious micro-organisms, particularly bacteria.
    Type: Application
    Filed: March 27, 2002
    Publication date: October 23, 2003
    Inventors: Peter E. Nielsen, Liam Good, Henrik Frydenlund Hansen, Frederik Beck, Leila Malik, Carsten Schou, Margit Wissenbach, Birgit Kjaeldgaard Giwercman
  • Modified peptide nucleic acid (PNA) molecules
    Publication number: 20030176325
    Abstract: The present invention relates to novel drugs which may be used in combating infectious micro-organisms, particularly bacteria.
    Type: Application
    Filed: October 19, 2001
    Publication date: September 18, 2003
    Applicant: Pantheco A/S and Peter E. Nielsen
    Inventors: Peter E. Nielsen, Liam Good, Henrik Frydenlund Hansen, Frederik Beck, Leila Malik, Carsten Schou, Margit Wissenbach, Birgit Kjaeldgaard Giwercman
  • Modified peptide nucleic acid (PNA) molecules
    Patent number: 6548651
    Abstract: The present invention relates to novel drugs which may be used in combating infectious micro-organisms, particularly bacteria. More specifically, the invention relates to peptide nucleic acid (PNA) sequences that are modified by conjugating cationic peptides to the PNA moiety in order to obtain novel PNA molecules that exhibit enhanced anti-infective properties.
    Type: Grant
    Filed: October 12, 2000
    Date of Patent: April 15, 2003
    Assignees: Pantheco A/S
    Inventors: Peter E. Nielsen, Liam Good, Henrik Frydenlund Hansen, Frederik Beck, Leila Malik, Carsten Schou, Margit Wissenbach, Birgit Kjaeldgaard Giwercman